Inventor · disambiguated record
Pierre Lafaye
Also filed as: LAFAYE PIERRE
15 granted patents·6 pending applications·69 citations·filing 2008–2022
90Inventor score
Files withPASTEUR INSTITUT11HOFFMANN LA ROCHE5CENTRE NAT RECH SCIENT1ECOLE SUPERIEURE PHYSIQUE & CHIMIE IND VILLE DE PARIS1LAFAYE PIERRE1
Top patents by PatentIndex Score
21 records- 0193US10948490B1Severe acute respiratory syndrome (SARS)—associated coronavirus diagnosticsPASTEUR INSTITUT·Filed 2020·Granted Mar 16, 2021·16 cites·18 claims
- 0291US8460888B2Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsLAFAYE PIERRE·Filed 2009·Granted Jun 11, 2013·38 cites·22 claims
- 0383US10087245B2Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereofHOFFMANN LA ROCHE·Filed 2015·Granted Oct 2, 2018·5 cites·25 claims
- 0478US11124563B2Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereofHOFFMANN LA ROCHE·Filed 2019·Granted Sep 21, 2021·1 cites·20 claims
- 0578US10538582B2Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jan 21, 2020·2 cites·20 claims
- 0678US9738712B2Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereofHOFFMANN LA ROCHE·Filed 2014·Granted Aug 22, 2017·5 cites·32 claims
- 0773US10155054B2Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsPASTEUR INSTITUT·Filed 2017·Granted Dec 18, 2018·1 cites·14 claims
- 0865US9387260B2VHH antibodies used as peptide vectors for delivering a substance of interestROUGEON FRANÇOIS·Filed 2009·Granted Jul 12, 2016·1 cites·27 claims
- 0962US11815513B2Severe acute respiratory syndrome (SARS)-associated coronavirus diagnosticsPASTEUR INSTITUT·Filed 2021·Granted Nov 14, 2023·0 cites·14 claims
- 1061US11339211B2Nanobodies suitable for neuron regeneration therapyPASTEUR INSTITUT·Filed 2020·Granted May 24, 2022·0 cites·10 claims
- 1155US10640552B2Nanobodies suitable for neuron regeneration therapyPASTEUR INSTITUT·Filed 2015·Granted May 5, 2020·0 cites·11 claims
- 1254US12326451B2Severe acute respiratory syndrome (SARS)—associated coronavirus diagnosticsPASTEUR INSTITUT·Filed 2020·Granted Jun 10, 2025·0 cites·18 claims
- 1353US2024361321A1Luminescent based antigen assayPASTEUR INSTITUT·Filed 2022·Application pending·0 cites
- 1453US2014206081A1Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsPASTEUR INSTITUT·Filed 2013·Application pending·0 cites
- 1552US10787505B2Oligopeptide and methods for producing conjugates thereofHOFFMANN LA ROCHE·Filed 2014·Granted Sep 29, 2020·0 cites·20 claims
- 1650US2024272176A1Single domain antibody specific for phosphorylated h2ax and its usesUNIV STRASBOURG·Filed 2022·Application pending·0 cites
- 1749US10174105B2Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applicationsPASTEUR INSTITUT·Filed 2016·Granted Jan 8, 2019·0 cites·10 claims
- 1849US2010266576A1Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applicationsCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 1944US10591466B2In vitro blood-brain barrier modelPASTEUR INSTITUT·Filed 2015·Granted Mar 17, 2020·0 cites·18 claims
- 2038US2018245144A1Paper device for genetic diagnosisECOLE SUPERIEURE PHYSIQUE & CHIMIE IND VILLE DE PARIS·Filed 2016·Application pending·0 cites
- 2132US2015322152A1Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shockPASTEUR INSTITUT·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →